Difference between revisions of "Editorial Board"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) |
Warner-admin (talk | contribs) |
||
Line 8: | Line 8: | ||
|- | |- | ||
| style="background-color:#F0F0F0; width: 25%;" |[[File:PeterYang.jpg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0; width: 25%;" |[[File:PeterYang.jpg|frameless|upright=0.4|center]] | ||
− | | style="width:35%" |<big>[[User:PeterYang|Peter C. Yang, MD]]<br>Boston, MA</big> | + | | style="width:35%" |<big>[[User:PeterYang|Peter C. Yang, MD]]<br>Boston, MA, USA</big> |
|Dr. Yang is board certified in Hematology and Medical Oncology; he practices at an academically affiliated institution in Massachusetts. | |Dr. Yang is board certified in Hematology and Medical Oncology; he practices at an academically affiliated institution in Massachusetts. | ||
|- | |- | ||
Line 16: | Line 16: | ||
|- | |- | ||
| style="background-color:#F0F0F0; width: 25%;" |[[File:Warner,_Jeremy_MD_2022.jpg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0; width: 25%;" |[[File:Warner,_Jeremy_MD_2022.jpg|frameless|upright=0.4|center]] | ||
− | | style="width:35%" |<big>[[User:Jwarner|Jeremy L. Warner, MD, MS, FAMIA, FASCO]]<br>Brown University<br>Providence, RI</big><br>[https://www.linkedin.com/in/jeremy-warner-39001512/ LinkedIn] | + | | style="width:35%" |<big>[[User:Jwarner|Jeremy L. Warner, MD, MS, FAMIA, FASCO]]<br>Brown University<br>Providence, RI, USA</big><br>[https://www.linkedin.com/in/jeremy-warner-39001512/ LinkedIn] |
|Dr. Warner is board certified in Hematology, Medical Oncology, and Clinical Informatics; he practices at the [https://www.lifespan.org/providers/jeremy-lyle-warner-md-ms-famia-fasco Lifespan Cancer Institute]. He is a [https://vivo.brown.edu/display/jwarne11 Professor of Medicine at Brown University]. He is the Director of the Brown/Lifespan Center for Clinical Cancer Informatics and Data Science (CCIDS). | |Dr. Warner is board certified in Hematology, Medical Oncology, and Clinical Informatics; he practices at the [https://www.lifespan.org/providers/jeremy-lyle-warner-md-ms-famia-fasco Lifespan Cancer Institute]. He is a [https://vivo.brown.edu/display/jwarne11 Professor of Medicine at Brown University]. He is the Director of the Brown/Lifespan Center for Clinical Cancer Informatics and Data Science (CCIDS). | ||
|- | |- | ||
Line 31: | Line 31: | ||
|- | |- | ||
| style="background-color:#F0F0F0; width:25%" |[[File:MartinSchoen.jpg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0; width:25%" |[[File:MartinSchoen.jpg|frameless|upright=0.4|center]] | ||
− | | style="width:35%" |<big>[[User:Marteens|Martin W. Schoen, MD, MPH]]<br>Saint Louis University<br>St. Louis, MO</big> | + | | style="width:35%" |<big>[[User:Marteens|Martin W. Schoen, MD, MPH]]<br>Saint Louis University<br>St. Louis, MO, USA</big> |
|Dr. Schoen is board certified in Hematology and Medical Oncology; he practices at the Saint Louis Veterans Affairs Medical Center. He is an assistant professor at [https://www.slu.edu/medicine/internal-medicine/hematology-medical-oncology/fellowship/fellows.php Saint Louis University]. | |Dr. Schoen is board certified in Hematology and Medical Oncology; he practices at the Saint Louis Veterans Affairs Medical Center. He is an assistant professor at [https://www.slu.edu/medicine/internal-medicine/hematology-medical-oncology/fellowship/fellows.php Saint Louis University]. | ||
|- | |- | ||
Line 37: | Line 37: | ||
|- | |- | ||
| style="background-color:#F0F0F0; width:25%" |[[File:Liang.jpg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0; width:25%" |[[File:Liang.jpg|frameless|upright=0.4|center]] | ||
− | | style="width:35%" |<big>[[User:Wayneliang|Wayne H. Liang, MD, MS, FAMIA]]<br>Emory University<br>Atlanta, GA</big><br>[https://www.linkedin.com/in/wayneliang/ LinkedIn] | + | | style="width:35%" |<big>[[User:Wayneliang|Wayne H. Liang, MD, MS, FAMIA]]<br>Emory University<br>Atlanta, GA, USA</big><br>[https://www.linkedin.com/in/wayneliang/ LinkedIn] |
|Dr. Liang is board certified in Pediatrics, Pediatric Hematology-Oncology, and Clinical Informatics; he practices at Children’s Healthcare of Atlanta. He is an Assistant Professor of Pediatrics at Emory University. | |Dr. Liang is board certified in Pediatrics, Pediatric Hematology-Oncology, and Clinical Informatics; he practices at Children’s Healthcare of Atlanta. He is an Assistant Professor of Pediatrics at Emory University. | ||
|- | |- | ||
Line 43: | Line 43: | ||
|- | |- | ||
| style="background-color:#F0F0F0; width:25%" |[[File:Bitterman.jpeg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0; width:25%" |[[File:Bitterman.jpeg|frameless|upright=0.4|center]] | ||
− | | style="width:35%" |<big>Danielle S. Bitterman, MD<br>Dana-Farber Cancer Institute<br>Boston, MA</big><br>[https://www.linkedin.com/in/danielle-bitterman-87834b16b/ LinkedIn] | + | | style="width:35%" |<big>Danielle S. Bitterman, MD<br>Dana-Farber Cancer Institute<br>Boston, MA, USA</big><br>[https://www.linkedin.com/in/danielle-bitterman-87834b16b/ LinkedIn] |
|Dr. Bitterman is board certified in Radiation Oncology; she practices at Brigham and Women’s Hospital/Dana-Farber Cancer Institute. She is an Assistant Professor of Radiation Oncology at Harvard Medical School. | |Dr. Bitterman is board certified in Radiation Oncology; she practices at Brigham and Women’s Hospital/Dana-Farber Cancer Institute. She is an Assistant Professor of Radiation Oncology at Harvard Medical School. | ||
|- | |- | ||
Line 49: | Line 49: | ||
|- | |- | ||
| style="background-color:#F0F0F0; width:25%" |[[File:Lustberg.jpeg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0; width:25%" |[[File:Lustberg.jpeg|frameless|upright=0.4|center]] | ||
− | | style="width:35%" |<big>Maryam B. Lustberg, MD, MPH<br>Yale University<br>New Haven, CT</big><br>[https://www.linkedin.com/in/maryam-lustberg-85578032/ LinkedIn] | + | | style="width:35%" |<big>Maryam B. Lustberg, MD, MPH<br>Yale University<br>New Haven, CT, USA</big><br>[https://www.linkedin.com/in/maryam-lustberg-85578032/ LinkedIn] |
|Dr. Lustberg is board certified in Medicine and Medical Oncology; she is the director of the Breast Center at Smilow Cancer Hospital and chief of Breast Medical Oncology at Yale Cancer Center. She is an Associate Professor of Internal Medicine (Medical Oncology) at Yale University. She is the co-chair of Symptom Intervention Committee for Alliance Clinical Trials, and the 2022 president of the Multinational Association of Cancer Supportive Care (MASCC) | |Dr. Lustberg is board certified in Medicine and Medical Oncology; she is the director of the Breast Center at Smilow Cancer Hospital and chief of Breast Medical Oncology at Yale Cancer Center. She is an Associate Professor of Internal Medicine (Medical Oncology) at Yale University. She is the co-chair of Symptom Intervention Committee for Alliance Clinical Trials, and the 2022 president of the Multinational Association of Cancer Supportive Care (MASCC) | ||
|- | |- | ||
Line 58: | Line 58: | ||
|- | |- | ||
| style="background-color:#F0F0F0; width:25%;" |[[File:Fernandes Hermina WEB160x200.jpg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0; width:25%;" |[[File:Fernandes Hermina WEB160x200.jpg|frameless|upright=0.4|center]] | ||
− | | style="width:35%" |<big>[[User:Herminafernandes|H. Deepika Fernandes, MD, FACP]]<br>Tempe, AZ</big> | + | | style="width:35%" |<big>[[User:Herminafernandes|H. Deepika Fernandes, MD, FACP]]<br>Tempe, AZ, USA</big> |
|Dr. Fernandes is board certified in Medical Oncology and Hematology; she practices at the [https://www.honorhealth.com/physicians/hermina-deepika-fernandes HonorHealth Virginia G. Piper Cancer Care Network]. | |Dr. Fernandes is board certified in Medical Oncology and Hematology; she practices at the [https://www.honorhealth.com/physicians/hermina-deepika-fernandes HonorHealth Virginia G. Piper Cancer Care Network]. | ||
|- | |- | ||
Line 64: | Line 64: | ||
|- | |- | ||
| style="background-color:#F0F0F0; width:25%;" |[[File:Bethbuchbinder.jpg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0; width:25%;" |[[File:Bethbuchbinder.jpg|frameless|upright=0.4|center]] | ||
− | | style="width:35%" |<big>[[User:Bethbuchbinder|Elizabeth Buchbinder, MD]]<br>Boston, MA</big><br>[https://www.linkedin.com/in/beth-buchbinder-2a9b994/ LinkedIn] | + | | style="width:35%" |<big>[[User:Bethbuchbinder|Elizabeth Buchbinder, MD]]<br>Boston, MA, USA</big><br>[https://www.linkedin.com/in/beth-buchbinder-2a9b994/ LinkedIn] |
|Dr. Buchbinder is board certified in Medical Oncology; she is a senior physician at the [https://www.dana-farber.org/find-a-doctor/elizabeth-i-buchbinder/ Dana-Farber Cancer Institute]. She is an Assistant Professor of Medicine at [http://www.dfhcc.harvard.edu/insider/member-detail/member/elizabeth-buchbinder-md/ Harvard Medical School]. | |Dr. Buchbinder is board certified in Medical Oncology; she is a senior physician at the [https://www.dana-farber.org/find-a-doctor/elizabeth-i-buchbinder/ Dana-Farber Cancer Institute]. She is an Assistant Professor of Medicine at [http://www.dfhcc.harvard.edu/insider/member-detail/member/elizabeth-buchbinder-md/ Harvard Medical School]. | ||
|- | |- | ||
Line 76: | Line 76: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:Traviszack.jpeg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:Traviszack.jpeg|frameless|upright=0.4|center]] | ||
− | |<big>Travis Zack MD, PhD<br>San Francisco, CA</big> | + | |<big>Travis Zack MD, PhD<br>San Francisco, CA, USA</big> |
|Dr. Zack is a senior hematology/oncology fellow at the University of California, San Francisco. | |Dr. Zack is a senior hematology/oncology fellow at the University of California, San Francisco. | ||
|- | |- | ||
Line 82: | Line 82: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:Eric Marks Headshot.jpg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:Eric Marks Headshot.jpg|frameless|upright=0.4|center]] | ||
− | |<big>[[User:Emarks|Eric I. Marks, MD]]<br>Boston, MA</big> | + | |<big>[[User:Emarks|Eric I. Marks, MD]]<br>Boston, MA, USA</big> |
|Dr. Marks is board certified in Medical Oncology; he practices at [https://www.bmc.org/about-us/directory/doctor/eric-marks-md Boston Medical Center] and is an Assistant Professor of Medicine at [https://www.bumc.bu.edu/busm/profile/eric-marks/ Boston University School of Medicine]. | |Dr. Marks is board certified in Medical Oncology; he practices at [https://www.bmc.org/about-us/directory/doctor/eric-marks-md Boston Medical Center] and is an Assistant Professor of Medicine at [https://www.bumc.bu.edu/busm/profile/eric-marks/ Boston University School of Medicine]. | ||
|- | |- | ||
Line 88: | Line 88: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:Alikhaki.jpg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:Alikhaki.jpg|frameless|upright=0.4|center]] | ||
− | |<big>[[User:Alikhaki|Ali Raza Khaki, MD]]<br>Palo Alto, CA</big> | + | |<big>[[User:Alikhaki|Ali Raza Khaki, MD]]<br>Palo Alto, CA, USA</big> |
|Dr. Khaki is board certified in Hematology and Medical Oncology; he practices at [https://stanfordhealthcare.org/doctors/k/ali-khaki.html Stanford Health Care]. He is a a Clinical Assistant Professor of Oncology at Stanford University School of Medicine. | |Dr. Khaki is board certified in Hematology and Medical Oncology; he practices at [https://stanfordhealthcare.org/doctors/k/ali-khaki.html Stanford Health Care]. He is a a Clinical Assistant Professor of Oncology at Stanford University School of Medicine. | ||
|- | |- | ||
Line 94: | Line 94: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:Brown-alaina.jpeg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:Brown-alaina.jpeg|frameless|upright=0.4|center]] | ||
− | |<big>[[User:AJBrown|Alaina J. Brown, MD, MPH]]<br>Nashville, TN</big> | + | |<big>[[User:AJBrown|Alaina J. Brown, MD, MPH]]<br>Nashville, TN, USA</big> |
|Dr. Brown is board certified in Gynecologic Oncology and Obstetrics and Gynecology; she practices at [https://www.vicc.org/member/alaina-brown the Vanderbilt-Ingram Cancer Center]. She is an Assistant Professor of Obstetrics and Gynecology at Vanderbilt University. | |Dr. Brown is board certified in Gynecologic Oncology and Obstetrics and Gynecology; she practices at [https://www.vicc.org/member/alaina-brown the Vanderbilt-Ingram Cancer Center]. She is an Assistant Professor of Obstetrics and Gynecology at Vanderbilt University. | ||
|- | |- | ||
Line 100: | Line 100: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:Choe.jpeg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:Choe.jpeg|frameless|upright=0.4|center]] | ||
− | |<big>Jennifer H. Choe, MD, PhD<br>Nashville, TN</big><br>[https://www.linkedin.com/in/jennifer-choe-925417b1/ LinkedIn] | + | |<big>Jennifer H. Choe, MD, PhD<br>Nashville, TN, USA</big><br>[https://www.linkedin.com/in/jennifer-choe-925417b1/ LinkedIn] |
|Dr. Choe is board certified in Internal Medicine and Medical Oncology; she practices at the Vanderbilt-Ingram Cancer Center, where she is the Head and Neck Medical Oncology Disease Team Lead and directs the clinical trials research program in the Division of Hematology and Oncology within the Department of Medicine at Vanderbilt University Medical Center. She specializes in cancers of the head and neck, thyroid, and non-melanoma skin cancers. | |Dr. Choe is board certified in Internal Medicine and Medical Oncology; she practices at the Vanderbilt-Ingram Cancer Center, where she is the Head and Neck Medical Oncology Disease Team Lead and directs the clinical trials research program in the Division of Hematology and Oncology within the Department of Medicine at Vanderbilt University Medical Center. She specializes in cancers of the head and neck, thyroid, and non-melanoma skin cancers. | ||
|- | |- | ||
Line 106: | Line 106: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:Zauderer-majorie.jpeg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:Zauderer-majorie.jpeg|frameless|upright=0.4|center]] | ||
− | |<big>Marjorie G. Zauderer, MD, MS, FACP<br>New York, NY</big> | + | |<big>Marjorie G. Zauderer, MD, MS, FACP<br>New York, NY, USA</big> |
|Dr. Zauderer is board certified in Medical Oncology; she is co-director of the mesothelioma program at [https://www.mskcc.org/cancer-care/doctors/marjorie-zauderer Memorial Sloan Kettering Cancer Center]. | |Dr. Zauderer is board certified in Medical Oncology; she is co-director of the mesothelioma program at [https://www.mskcc.org/cancer-care/doctors/marjorie-zauderer Memorial Sloan Kettering Cancer Center]. | ||
|- | |- | ||
Line 112: | Line 112: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:SeemaNagpal.jpg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:SeemaNagpal.jpg|frameless|upright=0.4|center]] | ||
− | |<big>[[User:Seemanagpal|Seema Nagpal, MD]]<br>Palo Alto, CA</big> | + | |<big>[[User:Seemanagpal|Seema Nagpal, MD]]<br>Palo Alto, CA, USA</big> |
|Dr. Nagpal is board certified in Neurology and UCNS certified in Neuro-Oncology; she practices at [https://stanfordhealthcare.org/doctors/n/seema-nagpal.html Stanford Health Care]. She is a clinical associate professor at [https://med.stanford.edu/profiles/seema-nagpal Stanford University] | |Dr. Nagpal is board certified in Neurology and UCNS certified in Neuro-Oncology; she practices at [https://stanfordhealthcare.org/doctors/n/seema-nagpal.html Stanford Health Care]. She is a clinical associate professor at [https://med.stanford.edu/profiles/seema-nagpal Stanford University] | ||
|- | |- | ||
Line 118: | Line 118: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:Elizabethdavis2.jpg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:Elizabethdavis2.jpg|frameless|upright=0.4|center]] | ||
− | |<big>[[User:Elizabethdavis|Elizabeth J. Davis, MD]]<br>Nashville, TN</big> | + | |<big>[[User:Elizabethdavis|Elizabeth J. Davis, MD]]<br>Nashville, TN, USA</big> |
|Dr. Davis is board certified in Medical Oncology; she practices at the Vanderbilt-Ingram Cancer Center and is the medical director of the Clinical Trials Office. She is an associate professor at [https://faculty.mc.vanderbilt.edu/Faculty/Details/44089 Vanderbilt University]. | |Dr. Davis is board certified in Medical Oncology; she practices at the Vanderbilt-Ingram Cancer Center and is the medical director of the Clinical Trials Office. She is an associate professor at [https://faculty.mc.vanderbilt.edu/Faculty/Details/44089 Vanderbilt University]. | ||
|- | |- | ||
Line 124: | Line 124: | ||
|- | |- | ||
| style="background-color:#F0F0F0 |[[File:Amit_Kulkarni.jpg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0 |[[File:Amit_Kulkarni.jpg|frameless|upright=0.4|center]] | ||
− | | style="width:35%" |<big>[[User:Akulkarni|Amit Kulkarni, MBBS]]<br>University of Minnesota<br>Minneapolis, MN</big> | + | | style="width:35%" |<big>[[User:Akulkarni|Amit Kulkarni, MBBS]]<br>University of Minnesota<br>Minneapolis, MN, USA</big> |
|Dr. Kulkarni is board certified in Medical Oncology; he practices and is an Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation at the [https://med.umn.edu/bio/hematology-oncology-and-transp/amit-kulkarni University of Minnesota]. | |Dr. Kulkarni is board certified in Medical Oncology; he practices and is an Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation at the [https://med.umn.edu/bio/hematology-oncology-and-transp/amit-kulkarni University of Minnesota]. | ||
|- | |- | ||
Line 130: | Line 130: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:AK.JPG|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:AK.JPG|frameless|upright=0.4|center]] | ||
− | |<big>Ashwin Kishtagari, MD<br>Vanderbilt University<br>Nashville, TN</big> | + | |<big>Ashwin Kishtagari, MD<br>Vanderbilt University<br>Nashville, TN, USA</big> |
|Dr. Kishtagari is board certified in Internal Medicine and Medical Oncology; he practices at [https://search.vanderbilthealth.com/doctors/kishtagari-ashwin Vanderbilt University Medical Center]. He is an Assistant Professor of Medicine (Hematology/Oncology) at [https://medschool.vanderbilt.edu/cancer-biology/person/ashwin-kishtagari-m-d/ Vanderbilt University]. | |Dr. Kishtagari is board certified in Internal Medicine and Medical Oncology; he practices at [https://search.vanderbilthealth.com/doctors/kishtagari-ashwin Vanderbilt University Medical Center]. He is an Assistant Professor of Medicine (Hematology/Oncology) at [https://medschool.vanderbilt.edu/cancer-biology/person/ashwin-kishtagari-m-d/ Vanderbilt University]. | ||
|- | |- | ||
Line 136: | Line 136: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:Sanjay_mohan.png|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:Sanjay_mohan.png|frameless|upright=0.4|center]] | ||
− | |<big>[[User:Sanjaymohan|Sanjay R. Mohan, MD, MSCI]]<br>Nashville, TN</big> | + | |<big>[[User:Sanjaymohan|Sanjay R. Mohan, MD, MSCI]]<br>Nashville, TN, USA</big> |
|Dr. Mohan is board certified in Hematology and Medical Oncology; he practices at the [http://www.vicc.org/dd/display.php?person=sanjay.mohan Vanderbilt-Ingram Cancer Center]. He is an assistant professor at [https://faculty.mc.vanderbilt.edu/Faculty/Details/37374 Vanderbilt University]. | |Dr. Mohan is board certified in Hematology and Medical Oncology; he practices at the [http://www.vicc.org/dd/display.php?person=sanjay.mohan Vanderbilt-Ingram Cancer Center]. He is an assistant professor at [https://faculty.mc.vanderbilt.edu/Faculty/Details/37374 Vanderbilt University]. | ||
|- | |- | ||
Line 142: | Line 142: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:TarsheenSethi.jpg|frameless|upright=0.3|center]] | | style="background-color:#F0F0F0" |[[File:TarsheenSethi.jpg|frameless|upright=0.3|center]] | ||
− | |<big>[[User:Tarsheensethi|Tarsheen K. Sethi, MD, MSCI]]<br>Yale University<br>New Haven, CT</big> | + | |<big>[[User:Tarsheensethi|Tarsheen K. Sethi, MD, MSCI]]<br>Yale University<br>New Haven, CT, USA</big> |
|Dr. Sethi is board certified in Hematology and Medical Oncology; she practices at the Smilow Cancer Hospital at Yale New Haven. She is an assistant professor at [https://medicine.yale.edu/profile/tarsheen_sethi/ Yale University]. | |Dr. Sethi is board certified in Hematology and Medical Oncology; she practices at the Smilow Cancer Hospital at Yale New Haven. She is an assistant professor at [https://medicine.yale.edu/profile/tarsheen_sethi/ Yale University]. | ||
|- | |- | ||
Line 148: | Line 148: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:Sanjaisharma.jpg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:Sanjaisharma.jpg|frameless|upright=0.4|center]] | ||
− | |<big>[[User:Sanjaisharma|Sanjai Sharma, MD]]<br>Visalia, CA</big> | + | |<big>[[User:Sanjaisharma|Sanjai Sharma, MD]]<br>Visalia, CA, USA</big> |
|Dr. Sharma is board certified in Hematology and Medical Oncology; he practices at the [https://www.kaweahdelta.org/Our-Services/Cancer-Center.aspx Sequoia Regional Cancer Center]. | |Dr. Sharma is board certified in Hematology and Medical Oncology; he practices at the [https://www.kaweahdelta.org/Our-Services/Cancer-Center.aspx Sequoia Regional Cancer Center]. | ||
|- | |- | ||
Line 154: | Line 154: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:Headshot Cowan.jpg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:Headshot Cowan.jpg|frameless|upright=0.4|center]] | ||
− | |<big>[[User:Andrewc072|Andrew J. Cowan, MD]]<br>Seattle, WA</big><br>[https://www.linkedin.com/in/andrew-cowan-63b3a130/ LinkedIn] | + | |<big>[[User:Andrewc072|Andrew J. Cowan, MD]]<br>Seattle, WA, USA</big><br>[https://www.linkedin.com/in/andrew-cowan-63b3a130/ LinkedIn] |
|Dr. Cowan is board certified in Hematology and Medical Oncology; he is the Interim Clinical Director of the myeloma service at the [https://www.seattlecca.org/providers/andrew-j-cowan Fred Hutch Cancer Center]. He is an associate professor at the [https://oncology.uw.edu/people/andrew-cowan University of Washington]. | |Dr. Cowan is board certified in Hematology and Medical Oncology; he is the Interim Clinical Director of the myeloma service at the [https://www.seattlecca.org/providers/andrew-j-cowan Fred Hutch Cancer Center]. He is an associate professor at the [https://oncology.uw.edu/people/andrew-cowan University of Washington]. | ||
|- | |- | ||
Line 160: | Line 160: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:Bdholaria.jpg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:Bdholaria.jpg|frameless|upright=0.4|center]] | ||
− | |<big>[[User:Bdholaria|Bhagirathbhai Dholaria, MBBS]]<br>Nashville, TN</big> | + | |<big>[[User:Bdholaria|Bhagirathbhai Dholaria, MBBS]]<br>Nashville, TN, USA</big> |
|Dr. Dholaria is board certified in Hematology and Medical Oncology; he practices at the [http://www.vicc.org Vanderbilt-Ingram Cancer Center]. He is an assistant professor at Vanderbilt University. | |Dr. Dholaria is board certified in Hematology and Medical Oncology; he practices at the [http://www.vicc.org Vanderbilt-Ingram Cancer Center]. He is an assistant professor at Vanderbilt University. | ||
|- | |- | ||
Line 166: | Line 166: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:GauravGoyal.jpg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:GauravGoyal.jpg|frameless|upright=0.4|center]] | ||
− | |<big>[[User:Ggoyal|Gaurav Goyal, MBBS]]<br>UAB<br>Birmingham, AL</big> | + | |<big>[[User:Ggoyal|Gaurav Goyal, MBBS]]<br>UAB<br>Birmingham, AL, USA</big> |
|Dr. Goyal is board certified in Hematology and Medical Oncology; he [https://providerdirectory.uabmedicine.org/provider/Gaurav+Goyal/895892 practices] at the O'Neal Comprehensive Cancer Center at UAB Medicine. He is an [https://scholars.uab.edu/display/ggoyal assistant professor] at UAB (The University of Alabama at Birmingham). | |Dr. Goyal is board certified in Hematology and Medical Oncology; he [https://providerdirectory.uabmedicine.org/provider/Gaurav+Goyal/895892 practices] at the O'Neal Comprehensive Cancer Center at UAB Medicine. He is an [https://scholars.uab.edu/display/ggoyal assistant professor] at UAB (The University of Alabama at Birmingham). | ||
|- | |- | ||
Line 172: | Line 172: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:Elaine fan.jpeg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:Elaine fan.jpeg|frameless|upright=0.4|center]] | ||
− | |<big>Elaine M. Fan, MD, MS<br>Wichita, KS</big> | + | |<big>Elaine M. Fan, MD, MS<br>Wichita, KS, USA</big> |
|Dr. Fan is an Assistant Professor of Pediatrics at the University of Kansas and practices at Wesley Medical Center. She is particularly interested in applying clinical informatics to improve clinical workflow efficiency, enhance provider and patient experience and, ultimately, improve health outcomes in pediatrics and pediatric hematology-oncology. Dr. Fan is board-certified in Pediatrics and board-eligible in Pediatric Hematology-Oncology. | |Dr. Fan is an Assistant Professor of Pediatrics at the University of Kansas and practices at Wesley Medical Center. She is particularly interested in applying clinical informatics to improve clinical workflow efficiency, enhance provider and patient experience and, ultimately, improve health outcomes in pediatrics and pediatric hematology-oncology. Dr. Fan is board-certified in Pediatrics and board-eligible in Pediatric Hematology-Oncology. | ||
|- | |- | ||
Line 178: | Line 178: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:Noyd.png|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:Noyd.png|frameless|upright=0.4|center]] | ||
− | |<big>David Noyd, MD, MPH<br>University of Washington<br>Seattle, WA</big> | + | |<big>David Noyd, MD, MPH<br>University of Washington<br>Seattle, WA, USA</big> |
|Dr. Noyd is board certified in Pediatrics and board eligible in Pediatric Hematology-Oncology; he practices at Seattle Children's Hospital. He is an Assistant Professor of Pediatrics at the University of Washington. | |Dr. Noyd is board certified in Pediatrics and board eligible in Pediatric Hematology-Oncology; he practices at Seattle Children's Hospital. He is an Assistant Professor of Pediatrics at the University of Washington. | ||
|- | |- | ||
Line 184: | Line 184: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:nwood.jpeg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:nwood.jpeg|frameless|upright=0.4|center]] | ||
− | |<big>[[User:Nwood|Nicole M. Wood, DO]]<br>University of Missouri<br>Kansas City, MO</big><br>[https://www.linkedin.com/in/nikki-wood-97587966/ LinkedIn] | + | |<big>[[User:Nwood|Nicole M. Wood, DO]]<br>University of Missouri<br>Kansas City, MO, USA</big><br>[https://www.linkedin.com/in/nikki-wood-97587966/ LinkedIn] |
|Dr. Wood is board certified in Pediatrics and Pediatric Hematology-Oncology; she practices at [https://www.childrensmercy.org/profiles/nikki-m-wood/ Children's Mercy Kansas City]. She is an Assistant Professor of Pediatrics at the University of Missouri. | |Dr. Wood is board certified in Pediatrics and Pediatric Hematology-Oncology; she practices at [https://www.childrensmercy.org/profiles/nikki-m-wood/ Children's Mercy Kansas City]. She is an Assistant Professor of Pediatrics at the University of Missouri. | ||
|- | |- | ||
Line 190: | Line 190: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:Hilal.jpg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:Hilal.jpg|frameless|upright=0.4|center]] | ||
− | |<big>[[User:THilal|Talal Hilal, MD]]<br>Mayo Clinic<br>Phoenix, AZ</big> | + | |<big>[[User:THilal|Talal Hilal, MD]]<br>Mayo Clinic<br>Phoenix, AZ, USA</big> |
|Dr. Hilal is board certified in Hematology and Medical Oncology; he practices at Mayo Clinic Arizona. He is an assistant professor at the Mayo Clinic. | |Dr. Hilal is board certified in Hematology and Medical Oncology; he practices at Mayo Clinic Arizona. He is an assistant professor at the Mayo Clinic. | ||
|- | |- | ||
Line 196: | Line 196: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:Tillman_Benjamin-2.jpg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:Tillman_Benjamin-2.jpg|frameless|upright=0.4|center]] | ||
− | |<big>[[User:Benjamintillman|Benjamin Tillman, MD]]<br>Vanderbilt University<br>Nashville, TN</big> | + | |<big>[[User:Benjamintillman|Benjamin Tillman, MD]]<br>Vanderbilt University<br>Nashville, TN, USA</big> |
|Dr. Tillman is board certified in Hematology and Medical Oncology; he practices at the [http://www.vicc.org Vanderbilt-Ingram Cancer Center]. He is an Assistant Professor of Medicine (Hematology/Oncology) | |Dr. Tillman is board certified in Hematology and Medical Oncology; he practices at the [http://www.vicc.org Vanderbilt-Ingram Cancer Center]. He is an Assistant Professor of Medicine (Hematology/Oncology) | ||
|- | |- | ||
Line 202: | Line 202: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:Fitts.jpeg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:Fitts.jpeg|frameless|upright=0.4|center]] | ||
− | |<big>[[User:Cafitts|Austin Fitts, PharmD]]<br>National Cancer Institute<br>Silver Springs, MD</big><br>[https://www.linkedin.com/in/austin-fitts/ LinkedIn] | + | |<big>[[User:Cafitts|Austin Fitts, PharmD]]<br>National Cancer Institute<br>Silver Springs, MD, USA</big><br>[https://www.linkedin.com/in/austin-fitts/ LinkedIn] |
|Dr. Fitts is a Postdoctoral Fellow at the National Cancer Institute. | |Dr. Fitts is a Postdoctoral Fellow at the National Cancer Institute. | ||
|- | |- | ||
Line 208: | Line 208: | ||
|- | |- | ||
| style="background-color:#F0F0F0" |[[File:Riaz.jpeg|frameless|upright=0.4|center]] | | style="background-color:#F0F0F0" |[[File:Riaz.jpeg|frameless|upright=0.4|center]] | ||
− | |<big>Irbaz Bin Riaz, MD, PhD, MS<br>Mayo Clinic<br>Phoenix, AZ</big> | + | |<big>Irbaz Bin Riaz, MD, PhD, MS<br>Mayo Clinic<br>Phoenix, AZ, USA</big> |
|Dr. Riaz is board certified in Internal Medicine and Medical Oncology; he is an Assistant Professor of Medicine at Mayo Clinic, Arizona. | |Dr. Riaz is board certified in Internal Medicine and Medical Oncology; he is an Assistant Professor of Medicine at Mayo Clinic, Arizona. | ||
|- | |- |
Revision as of 16:04, 22 September 2023
Our editorial board is comprised of cancer experts, organized primarily by disease focus. If you are interested in getting involved, please feel free to contact us with any questions or inquiries, at contact @ hemonc.org.
Editor-in-Chief
Peter C. Yang, MD Boston, MA, USA |
Dr. Yang is board certified in Hematology and Medical Oncology; he practices at an academically affiliated institution in Massachusetts. |
Deputy Editor
Jeremy L. Warner, MD, MS, FAMIA, FASCO Brown University Providence, RI, USA |
Dr. Warner is board certified in Hematology, Medical Oncology, and Clinical Informatics; he practices at the Lifespan Cancer Institute. He is a Professor of Medicine at Brown University. He is the Director of the Brown/Lifespan Center for Clinical Cancer Informatics and Data Science (CCIDS). |
Associate Editors
Cancer Registries | ||
---|---|---|
Mary Mesnard, BS, CTR |
Ms. Mesnard is a senior study director at Westat and was formerly with the State of Maryland's central cancer registry. | |
Evidence-based Oncology | ||
Martin W. Schoen, MD, MPH Saint Louis University St. Louis, MO, USA |
Dr. Schoen is board certified in Hematology and Medical Oncology; he practices at the Saint Louis Veterans Affairs Medical Center. He is an assistant professor at Saint Louis University. | |
Pediatric Hematology/Oncology | ||
Wayne H. Liang, MD, MS, FAMIA Emory University Atlanta, GA, USA |
Dr. Liang is board certified in Pediatrics, Pediatric Hematology-Oncology, and Clinical Informatics; he practices at Children’s Healthcare of Atlanta. He is an Assistant Professor of Pediatrics at Emory University. | |
Radiation Oncology | ||
Danielle S. Bitterman, MD Dana-Farber Cancer Institute Boston, MA, USA |
Dr. Bitterman is board certified in Radiation Oncology; she practices at Brigham and Women’s Hospital/Dana-Farber Cancer Institute. She is an Assistant Professor of Radiation Oncology at Harvard Medical School. | |
Supportive Oncology | ||
Maryam B. Lustberg, MD, MPH Yale University New Haven, CT, USA |
Dr. Lustberg is board certified in Medicine and Medical Oncology; she is the director of the Breast Center at Smilow Cancer Hospital and chief of Breast Medical Oncology at Yale Cancer Center. She is an Associate Professor of Internal Medicine (Medical Oncology) at Yale University. She is the co-chair of Symptom Intervention Committee for Alliance Clinical Trials, and the 2022 president of the Multinational Association of Cancer Supportive Care (MASCC) |
Section Editors
Breast Oncology | ||
---|---|---|
H. Deepika Fernandes, MD, FACP Tempe, AZ, USA |
Dr. Fernandes is board certified in Medical Oncology and Hematology; she practices at the HonorHealth Virginia G. Piper Cancer Care Network. | |
Dermatologic Oncology | ||
Elizabeth Buchbinder, MD Boston, MA, USA |
Dr. Buchbinder is board certified in Medical Oncology; she is a senior physician at the Dana-Farber Cancer Institute. She is an Assistant Professor of Medicine at Harvard Medical School. | |
Endocrine Oncology | ||
Unfilled | If you are interested in this role, please contact us at contact @ hemonc.org. | |
Gastrointestinal Oncology, Intestinal | ||
Travis Zack MD, PhD San Francisco, CA, USA |
Dr. Zack is a senior hematology/oncology fellow at the University of California, San Francisco. | |
Gastrointestinal Oncology, Extraintestinal | ||
Eric I. Marks, MD Boston, MA, USA |
Dr. Marks is board certified in Medical Oncology; he practices at Boston Medical Center and is an Assistant Professor of Medicine at Boston University School of Medicine. | |
Genitourinary Oncology | ||
Ali Raza Khaki, MD Palo Alto, CA, USA |
Dr. Khaki is board certified in Hematology and Medical Oncology; he practices at Stanford Health Care. He is a a Clinical Assistant Professor of Oncology at Stanford University School of Medicine. | |
Gynecologic Oncology | ||
Alaina J. Brown, MD, MPH Nashville, TN, USA |
Dr. Brown is board certified in Gynecologic Oncology and Obstetrics and Gynecology; she practices at the Vanderbilt-Ingram Cancer Center. She is an Assistant Professor of Obstetrics and Gynecology at Vanderbilt University. | |
Head & Neck Cancer | ||
Jennifer H. Choe, MD, PhD Nashville, TN, USA |
Dr. Choe is board certified in Internal Medicine and Medical Oncology; she practices at the Vanderbilt-Ingram Cancer Center, where she is the Head and Neck Medical Oncology Disease Team Lead and directs the clinical trials research program in the Division of Hematology and Oncology within the Department of Medicine at Vanderbilt University Medical Center. She specializes in cancers of the head and neck, thyroid, and non-melanoma skin cancers. | |
Mesothelioma | ||
Marjorie G. Zauderer, MD, MS, FACP New York, NY, USA |
Dr. Zauderer is board certified in Medical Oncology; she is co-director of the mesothelioma program at Memorial Sloan Kettering Cancer Center. | |
Neuro-Oncology | ||
Seema Nagpal, MD Palo Alto, CA, USA |
Dr. Nagpal is board certified in Neurology and UCNS certified in Neuro-Oncology; she practices at Stanford Health Care. She is a clinical associate professor at Stanford University | |
Sarcoma | ||
Elizabeth J. Davis, MD Nashville, TN, USA |
Dr. Davis is board certified in Medical Oncology; she practices at the Vanderbilt-Ingram Cancer Center and is the medical director of the Clinical Trials Office. She is an associate professor at Vanderbilt University. | |
Thoracic Oncology | ||
Amit Kulkarni, MBBS University of Minnesota Minneapolis, MN, USA |
Dr. Kulkarni is board certified in Medical Oncology; he practices and is an Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation at the University of Minnesota. | |
Acute Leukemias | ||
Ashwin Kishtagari, MD Vanderbilt University Nashville, TN, USA |
Dr. Kishtagari is board certified in Internal Medicine and Medical Oncology; he practices at Vanderbilt University Medical Center. He is an Assistant Professor of Medicine (Hematology/Oncology) at Vanderbilt University. | |
Myeloproliferative Neoplasms and Myelodysplastic Syndromes | ||
Sanjay R. Mohan, MD, MSCI Nashville, TN, USA |
Dr. Mohan is board certified in Hematology and Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an assistant professor at Vanderbilt University. | |
Aggressive Lymphomas & Lymphoproliferative disorders | ||
Tarsheen K. Sethi, MD, MSCI Yale University New Haven, CT, USA |
Dr. Sethi is board certified in Hematology and Medical Oncology; she practices at the Smilow Cancer Hospital at Yale New Haven. She is an assistant professor at Yale University. | |
Indolent Lymphomas | ||
Sanjai Sharma, MD Visalia, CA, USA |
Dr. Sharma is board certified in Hematology and Medical Oncology; he practices at the Sequoia Regional Cancer Center. | |
Plasma Cell Dyscrasias | ||
Andrew J. Cowan, MD Seattle, WA, USA |
Dr. Cowan is board certified in Hematology and Medical Oncology; he is the Interim Clinical Director of the myeloma service at the Fred Hutch Cancer Center. He is an associate professor at the University of Washington. | |
T-cell and NK-cell neoplasms | ||
Bhagirathbhai Dholaria, MBBS Nashville, TN, USA |
Dr. Dholaria is board certified in Hematology and Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an assistant professor at Vanderbilt University. | |
Histiocyte Disorders | ||
Gaurav Goyal, MBBS UAB Birmingham, AL, USA |
Dr. Goyal is board certified in Hematology and Medical Oncology; he practices at the O'Neal Comprehensive Cancer Center at UAB Medicine. He is an assistant professor at UAB (The University of Alabama at Birmingham). | |
Pediatric Blastomas & Extracranial Germ Cell Tumors | ||
Elaine M. Fan, MD, MS Wichita, KS, USA |
Dr. Fan is an Assistant Professor of Pediatrics at the University of Kansas and practices at Wesley Medical Center. She is particularly interested in applying clinical informatics to improve clinical workflow efficiency, enhance provider and patient experience and, ultimately, improve health outcomes in pediatrics and pediatric hematology-oncology. Dr. Fan is board-certified in Pediatrics and board-eligible in Pediatric Hematology-Oncology. | |
Pediatric Leukemia & Lymphoma | ||
David Noyd, MD, MPH University of Washington Seattle, WA, USA |
Dr. Noyd is board certified in Pediatrics and board eligible in Pediatric Hematology-Oncology; he practices at Seattle Children's Hospital. He is an Assistant Professor of Pediatrics at the University of Washington. | |
Pediatric Neuro-Oncology & Solid Tumors | ||
Nicole M. Wood, DO University of Missouri Kansas City, MO, USA |
Dr. Wood is board certified in Pediatrics and Pediatric Hematology-Oncology; she practices at Children's Mercy Kansas City. She is an Assistant Professor of Pediatrics at the University of Missouri. | |
Transplant | ||
Talal Hilal, MD Mayo Clinic Phoenix, AZ, USA |
Dr. Hilal is board certified in Hematology and Medical Oncology; he practices at Mayo Clinic Arizona. He is an assistant professor at the Mayo Clinic. | |
Classical Hematology | ||
Benjamin Tillman, MD Vanderbilt University Nashville, TN, USA |
Dr. Tillman is board certified in Hematology and Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an Assistant Professor of Medicine (Hematology/Oncology) | |
Clinical Pharmacology | ||
Austin Fitts, PharmD National Cancer Institute Silver Springs, MD, USA |
Dr. Fitts is a Postdoctoral Fellow at the National Cancer Institute. | |
Living Systematic Reviews | ||
Irbaz Bin Riaz, MD, PhD, MS Mayo Clinic Phoenix, AZ, USA |
Dr. Riaz is board certified in Internal Medicine and Medical Oncology; he is an Assistant Professor of Medicine at Mayo Clinic, Arizona. |
Page Editors
- Jon Arnason, MD (Beth Israel Deaconess Medical Center, Boston, MA, USA)
- Brianna Bakow, MD (Brigham and Women's Hospital, Boston, MA, USA)
- Teja Ganta, MD (Icahn School of Medicine at Mount Sinai, Manhattan, NY, USA)
- Michael J. Glover, MD (Stanford University, Palo Alto, CA, USA)
- Laura S. Graham, MD (University of Colorado, Anschutz Medical Campus, Aurora, CO, USA)
- Matthew Hadfield, DO (Lifespan/Brown University, Providence, RI, USA)
- C. Beau Hilton, MD (Vanderbilt University, Nashville, TN, USA)
- Shalin Kothari, MD (Yale University, New Haven, CT, USA)
- Mary L. Kwok, MD, FACP (Fred Hutch Cancer Center, Seattle, WA, USA)
- Emily A. Mann, MD (Boston University, Boston, MA, USA)
- Eric I. Marks, MD (Boston University, Boston, MA, USA)
- Francesca Montanari, MD (Yale University, New Haven, CT, USA)
- Ryan H. Nguyen, DO (University of Illinois at Chicago, IL, USA)
- Michael K. Rooney, MD (MD Anderson Cancer Center, Houston, TX, USA)
- Samuel M. Rubinstein, MD (University of North Carolina, Chapel Hill, NC, USA)
- Eric K. Singhi, MD (MD Anderson Cancer Center, Houston, TX, USA)
- Leyre Zubiri, MD, PhD (Massachusetts General Hospital, Boston, MA, USA)
COI Disclosures
Please see our conflict of interest page for more details. Disclosures here are for COI within 24 months of the date of disclosure unless otherwise noted.
Name | Research funding (to institution) | Other (honoraria, travel support, significant ownership interests, etc.) | Date of disclosure |
---|---|---|---|
Jon Arnason | Nothing to disclose | Speaker: Bristol-Myers Squibb | 2023-06-28 |
Brianna Bakow | Nothing to disclose | Nothing to disclose | 2023-08-27 |
Danielle S. Bitterman | Nothing to disclose | Nothing to disclose | 2023-08-03 |
Alaina J. Brown | NIH | Nothing to disclose | 2022-08-03 |
Elizabeth Buchbinder | Clinical trial support from Lilly, Novartis, Partners therapeutics, Genentech and BVD. | Consulting as an advisory board member for Merck, Iovance, Sanofi, Xilio, Novartis, Instilbio, and Nektar. | 2023-06-28 |
Andrew Cowan | Abbvie, Nektar, Harpoon, Janssen, Adaptive, Sanofi, BMS, Celgene | Consultancy: Abbvie, BMS, Secura Bio, EUSA, GSK | 2022-04-26 |
Elizabeth J. Davis | Trial funding: Karyopharm, Bristol Myers Squibb, Incyte, Actuate, InhibRx, Top Alliance BioSciences, Genentech, Five Prime Therapeutics | Consulting/Advisory Board: Deciphera, Aadi Honoraria: MJH Life Sciences Speakers' Bureau: Physicians' Education Resource |
2023-01-03 |
Bhagirathbhai Dholaria | Research funding: Janssen, Angiocrine, Pfizer, Poseida, MEI, Orcabio, Wugen, Allovir | Consulting/Advisory Board: Jazz, Gamida Cell, MJH BioScience, Arivan Research, BEAM therapeutics, Janssen, Atheneum; Study steering committee: Gamida Cell | 2022-08-04 |
Elaine Fan | Nothing to disclose | Consulting: Westat | 2023-09-09 |
H. Deepika Fernandes | Nothing to disclose | Nothing to disclose | 2023-06-28 |
Austin Fitts | Nothing to disclose | Consulting: Westat | 2023-01-03 |
Teja Ganta | Nothing to disclose | Other: Epic Systems, Analog Devices | 2023-09-05 |
Michael J. Glover | Nothing to disclose | Nothing to disclose | 2023-04-15 |
Gaurav Goyal | Nothing to disclose | Royalties from UpToDate and consulting fees from 2nd.MD | 2022-08-02 |
Laura Graham | Nothing to disclose | Nothing to disclose | 2022-08-04 |
Matthew Hadfield | Nothing to disclose | Nothing to disclose | 2022-11-17 |
Talal Hilal | Nothing to disclose | Consulting/Advisory Board: Incyte Editorship: Springer |
2022-08-22 |
Ali R. Khaki | Janssen, 23andMe | Consulting/Advisory Board: Seagen/Astellas Travel: BCAN; SABCS Honoraria: Onclive CME |
2023-09-01 |
Ashwin Kishtagari | Nothing to disclose | Consulting/Advisory Board: CTI BioPharma, Geron, Servier | 2023-08-03 |
Shalin Kothari | Nothing to disclose | Nothing to disclose | 2023-08-10 |
Amit Kulkarni | Research Funding to Institution: Astra Zeneca | Consulting/Advisory Board: Genentech, Exelixis; Speaker Beaureu: Regneron; Stock and Other Ownership Interests: Fate Therapeutics, Merck, Exact Sciences, Gilead Sciences, Mirati Therapeutics, Novavax | 2022-11-26 |
Mary L. Kwok | BeiGene | Nothing to disclose | 2023-06-28 |
Wayne H. Liang | Nothing to disclose | Consulting/Advisory Board: Westat | 2021-11-10 |
Maryam Lustberg | Nothing to disclose | Consulting/Advisory Board: Pfizer, Gilead, Novartis, Eli Lilly, AstraZeneca | 2023-07-04 |
Emily A. Mann | Nothing to disclose | Nothing to disclose | 2023-08-25 |
Eric Marks | Research funding: Merck | Consulting/Advisory Board: Sermo, Medscape, Brand Institute, M3 | 2023-06-28 |
Mary Mesnard | Nothing to disclose | Nothing to disclose | 2023-08-03 |
Sanjay R. Mohan | Research funding: NCCN, Ichnos, Incyte, Kartos, Karyopharm, Taiho | Nothing to disclose | 2023-08-24 |
Francesca Montanari | Nothing to disclose | Nothing to disclose | 2023-06-29 |
Seema Nagpal | Trial funding: Agios, PharmAbcine, Insightec, Berg, Inovio | Consulting/Advisory Board: EnClear, SeaGen, Novocure Steering Committee, Nurix, Biocept Steering Committee; Guidelines: NCCN CNS committee, ARS-AUC CNS committee, ASTRO Brain metastases guideline committee | 2022-04-22 |
Ryan Nguyen | Nothing to disclose | Nothing to disclose | 2022-08-04 |
David Noyd | Nothing to disclose | Nothing to disclose | 2023-08-03 |
Irbaz Bin Riaz | Nothing to disclose | Nothing to disclose | 2023-08-10 |
Michael K. Rooney | Nothing to disclose | Nothing to disclose | 2023-08-14 |
Samuel R. Rubinstein | Nothing to disclose | Consulting/Advisory Board: Sanofi, Roche, Janssen, EUSA pharma | 2022-08-03 |
Martin Schoen | St. Louis Veterans Affairs Medical Center, Congressionally Directed Medical Research Program | Consulting/Advisory Board: Doximity, Pfizer | 2023-08-11 |
Sanjai Sharma | Nothing to disclose | Nothing to disclose | 2022-08-04 |
Eric K. Singhi | Nothing to disclose | Consulting/Advisory Board: AstraZeneca | 2023-08-10 |
Benjamin F. Tillman | Nothing to disclose | Nothing to disclose | 2023-01-29 |
Jeremy L. Warner | AACR; NIH; Brown Physicians Incorporated | Travel: AACR; ASCO Ownership: HemOnc.org Consulting/Advisory Board: Westat, MelaxTech Editorship: ASCO |
2022-12-29 |
Nicole M. Wood | Nothing to disclose | Consulting/Advisory Board: Westat | 2023-08-07 |
Peter C. Yang | Nothing to disclose | Ownership: HemOnc.org Stock: Merck, Pfizer |
2023-06-29 |
Marjorie Zauderer | Memorial Sloan Kettering receives research funding from the Department of Defense, the National Institutes of Health, Precog, GlaxoSmithKline, Epizyme, MedImmune, Polaris, Sellas Life Sciences, Vivace, Bristol Myers Squibb, Millenium/Takeda, Curis, and Atara for research conducted by Dr. Zauderer. | In the last 3 years, Dr. Zauderer has received consulting fees from Curis, Ikena, Takeda, GlaxoSmithKline, Aldeyra Therapeutics, Novocure, and Atara and honoraria for CME content from PER, Medscape, Research to Practice, Medical Learning Institute and OncLive. Dr. Zauderer serves as Chair of the Board of Directors of the Mesothelioma Applied Research Foundation, uncompensated. | 2023-08-08 |
Leyre Zubiri | Nothing to disclose | Honoraria: Merck | 2022-08-22 |